Drug notes:
RVL002 RD CNS and metabolic diseases
About:
Unravel Biosciences is unraveling the complexities of gene function and regulation to advance our understanding of human biology and disease. Integrating a high-throughput in vivo screening platform with advanced computational analysis techniques, Unravel identifies potential targets and compounds in order to develop novel therapies. Their gene network analysis, which processes expansive RNA datasets, helps identify the molecular signatures of a disease in an individual patient. This technology allows for the production of personalized medicines for diseases with limited or no treatment options. Unravel’s mission is to reduce the time from years to weeks in determining and validating disease-drug matches, in a more affordable fashion.